Immunotherapy with Tolerogenic Dendritic Cells Alone or in Combination with Rapamycin Does Not Reverse Diabetes in NOD Mice
Endogenous insulin secretion ameliorates in mice treated with rapamycin but the effect is counteracted when combined with tolerogenic DCs. Serum C-peptide levels determined by ELISA at the end of the follow-up (30 days). Data from 3–6 animals/group are expressed as means ± SD. Means significant differences, .